According to UK Cystic Fibrosis (CF) Registry data, 89% of people receiving treatment for CFRD are prescribed insulin, and the corresponding figure from the US CF Registry is 81% [15, 16], which equates to approximately a third of all adults with CF in each country receiving insulin. The gene discussed is INS; the disease is cystic fibrosis.